¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22
±³À°ÀÏÀÚ : 2022-10-22
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2022 Samsung-Mayo Clinic Heart Symposium
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼øȯ±â³»°ú  
´ã´çÀÚ : ÀåÇý¼÷
¿¬¶ôó : 02-3410-3792  
À̸ÞÀÏ : hs0129.jang@samsung.com      
±³À°Á¾·ù : ³»°ú±âŸ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 08:45~09:00 Pathophysiology of HFpEF  Omar F. Abou Ezzeddine(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:00~09:15 Cardiac Amyloidosis: diagnostic challenge  ±è´Ù·¡(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:15~09:30 Coronary microvascular dysfunction in HFpEF  ÃÖ±âÈ«(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:30~09:45 Excersise stress test in HFpEF  Jae K. Oh(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:45~10:00 Promising treatment candidates in HFpEF  Atta Behfar(Mayo Clinic, USA) 
Åä·Ð 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 10:00~10:30 Discussion  () 
È޽Ġ10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 10:30~10:45 Coffee break  () 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 10:45~11:00 Acute RV failure : assessment and management with critical care medicine   À强¾Æ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:00~11:15 New tools to prevent SCD: the Extravascular ICD   Paul A. Friedman(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:15~11:30 Diagnostic conundrums in HFrEF: My tip and tricks  Omar F. Abou Ezzeddine(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:30~11:45 Latest update on new medical treatment in HFrEF  ÃÖÁø¿À(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:45~12:00 Revascularization strategy in ischemic cardiomyopathy: CABG PCI OMT  ÀÌÁÖ¸í(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 12:00~12:15 From Silicone to Clinical Trials and Bedside to Home: AI to predict and detect ventricular dysfunction.  Paul A. Friedman(Mayo Clinic, USA) 
Åä·Ð 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 12:15~12:45 Discussion  () 
½Ä»ç 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 12:45~13:30 Lunch  () 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 13:30~13:45 CRT in NYHA IV patients on inotropes  ¹Ú½ÂÁ¤(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 13:45~14:00 TAVR in congestive heart failure  Mayra Guerrero(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:00~14:15 Percutaneous intervention for severe MR and TR  Mayra Guerrero(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:15~14:30 Optimal weaning strategy in VA ECMO  ¾çÁ¤ÈÆ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:30~14:45 Optimal maintenance therapy after LVAD implantation  Atta Behfar(Mayo Clinic, USA) 
Åä·Ð 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:45~15:15 Discussion  () 
È޽Ġ10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 15:15~15:30 Coffee break  () 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 15:30~15:45 Artificial Intelligence Basics: What the Clinician needs to know.  ±èÁÖ¿¬(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 15:45~16:00 Current status of Echo AI  Jae K. Oh(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 16:00~16:15 Current status of Hemodynamic monitoring AI  ±ÇÁظí(¸ÞµðÄÿ¡À̾ÆÀÌ/¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 16:15~16:30 Machine Learning to Assist Accurate Clinical Decision in valvular heart disease  À̽ÂÇ¥(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 16:30~16:45 AI to Find Hidden Atrial Fibrillation: State of the Art  Paul A. Friedman(Mayo Clinic, USA) 
Åä·Ð 10-22  16:45~17:15 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2022 Çѱ¹ºÐ¼®½É¸®ÇÐȸ Ãß°èÇмú´ëȸ : 2022-10-22
´ÙÀ½±Û Á¦7Â÷ ´ëÇѼչßÅéÇÐȸ Çмú´ëȸ : 2022-10-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 11 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 23 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 16 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 10 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 7 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 4 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 6 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 10 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 6 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 5 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 12 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 6 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 10 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 5 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 6 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷